Mitochondria Targeted Protein-Ruthenium Photosensitizer for Efficient Photodynamic Applications
Author(s) -
Sabyasachi Chakrabortty,
Bikram Keshari Agrawalla,
Anne Stumper,
Vegi M. Naidu,
Stephan Fischer,
C. L. Reichardt,
Michael R. Kogler,
Benjamin Dietzek,
Michaela FeuringBuske,
Christian Buske,
Sven Rau,
Tanja Weil
Publication year - 2017
Publication title -
journal of the american chemical society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.115
H-Index - 612
eISSN - 1520-5126
pISSN - 0002-7863
DOI - 10.1021/jacs.6b13399
Subject(s) - photosensitizer , photodynamic therapy , phototoxicity , chemistry , ruthenium , mitochondrion , organelle , cell culture , myeloid leukemia , cancer research , biophysics , biochemistry , photochemistry , in vitro , organic chemistry , biology , genetics , catalysis
Organelle-targeted photosensitization represents a promising approach in photodynamic therapy where the design of the active photosensitizer (PS) is very crucial. In this work, we developed a macromolecular PS with multiple copies of mitochondria-targeting groups and ruthenium complexes that displays highest phototoxicity toward several cancerous cell lines. In particular, enhanced anticancer activity was demonstrated in acute myeloid leukemia cell lines, where significant impairment of proliferation and clonogenicity occurs. Finally, attractive two-photon absorbing properties further underlined the great significance of this PS for mitochondria targeted PDT applications in deep tissue cancer therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom